Factors associated with poor response to lithium carbonate: a clinical study.
D015065:17-Hydroxycorticosteroids / Q000652:urine*; D000328:Adult; D000342:Affective Symptoms / Q000188:drug therapy; D001519:Behavior / Q000187:drug effects; D001714:Bipolar Disorder / Q000188:drug therapy*; D002254:Carbonates; D002746:Chlorpromazine / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003674:Defense Mechanisms; D004644:Emotions / Q000187:drug effects; D005260:Female; D006117:Grief; D006801:Humans; D008094:Lithium / Q000008:administration & dosage* / Q000097:blood / Q000378:metabolism / Q000652:urine; D010919:Placebos; D012559:Schizophrenia / Q000188:drug therapy*; D013315:Stress, Psychological / Q000187:drug effects*; D014273:Triflupromazine / Q000627:therapeutic use; D014705:Verbal Behavior
D015065:17-Hydroxycorticosteroids; D002254:Carbonates; D010919:Placebos; D008094:Lithium; D014273:Triflupromazine; D002746:Chlorpromazine